Market Update – Indonesian Equity Landscape
The Indonesian equity market closed on a subdued note this Wednesday, with Yupi Indo Jelly Gum (YUPI.JK) registering a 3.9 % decline in its 24‑hour trading session. The stock is presently priced at approximately IDR 1,020 per share on the main exchanges, a modest discount to its 52‑week low of IDR 955 set on 20 October 2026. Despite a sharp 23.35 % year‑to‑date slide, Yupi remains a significant player, with a market capitalization of IDR 9.4 trillions and a circulating supply of 8.5 billion shares. The most recent 24‑hour trading volume amounted to roughly IDR 57.6 million.
Technical Snapshot
- 200‑Day Simple Moving Average: IDR 1,430.2
- 52‑Week High: IDR 2,040 (26 June 2026)
- 52‑Week Low: IDR 955 (20 October 2026)
The current price sits well below the 200‑day average, suggesting that momentum is weak and a reversal will require a substantial catalyst. Analysts anticipate that a bullish shift could be triggered by a favorable earnings report or an upstream supply agreement that improves margin outlooks.
Peer Performance Overview
In comparison to its sector peers, YUPI.JK’s decline is outpaced by the broader market. The following table summarises the latest 24‑hour performance of related stocks:
| Ticker | % Change | Current Price (IDR) | Market Cap (IDR) | P/E Ratio |
|---|---|---|---|---|
| SGER.JK | +3.57 % | 755 | 11.1 trillions | 53.52 |
| CARE.JK | 0 % | 372 | 10.6 trillions | 1,962.62 |
| STTP.JK | +2.13 % | 8,550 | 11.2 trillions | 8.89 |
| SMMT.JK | +5.36 % | 3,100 | 10.3 trillions | 135.78 |
| TSPC.JK | +0.42 % | 2,400 | 11.1 trillions | 7.23 |
While Sumber Global Energy (SGER.JK) and Golden Eagle Energy (SMMT.JK) enjoy notable upside, Metro Healthcare (CARE.JK) remains stagnant, and Tempo Scan Pacific (TSPC.JK) shows only marginal growth. These dynamics suggest that Yupi’s recent slide may be an isolated event rather than a sector-wide shift.
Forward‑Looking Perspective
From an insider standpoint, several factors could steer Yupi Indo Jelly Gum back toward a bullish trajectory:
- Commodity Price Recovery – A rebound in global confectionery raw‑material prices would lift Yupi’s margin profile.
- Strategic Partnerships – Potential joint ventures with regional distributors could unlock new market segments.
- Regulatory Environment – Upcoming changes in the Indonesian Food and Drug Administration (BPOM) approval process may expedite product launches, enhancing revenue streams.
Given the current price disparity relative to the 200‑day SMA, traders might view a rebound as a compelling opportunity. However, the stock’s low liquidity, coupled with its historically volatile P/E ratio, mandates prudent risk assessment.
In conclusion, while Yupi Indo Jelly Gum faces a short‑term headwind, the confluence of macro‑economic tailwinds and possible strategic initiatives positions the company for a potential turnaround. Market participants should monitor earnings guidance, supply chain developments, and broader commodity trends to gauge the stock’s resilience in the weeks ahead.
